Efficacy of different antidiabetic drugs based on metformin in the treatment of type 2 diabetes mellitus: A network meta-analysis involving eight eligible randomized-controlled trials

Journal of Cellular Physiology
Yan PengQing-Yun Sun

Abstract

Diabetes mellitus is one of the most prevalent metabolic diseases globally and it is increasing in prevalence. It is one of the most expensive diseases with respect to total health care costs per patient as a result of its chronic nature and its severe complications. To provide a more effective treatment of type 2 diabetes mellitus (T2DM), this study aims to compare different efficacies of six kinds of hypoglycemic drugs based on metformin, including glimepiride, pioglitazone, exenatide, glibenclamide, rosiglitazone, and vildagliptin, in T2DM by a network meta-analysis that were verified by randomized-controlled trials (RCTs). Eight eligible RCT in consistency with the aforementioned six hypoglycemic drugs for T2DM were included. The results of network meta-analysis demonstrated that the exenatide + metformin and vildagliptin + metformin regimens presented with better efficacy. Patients with T2DM with unsatisfactory blood glucose control based on diet control, proper exercise, and metformin treatment were included. The original regimen and dose of medication were unchanged, followed by the addition of glimepiride, pioglitazone, exenatide, glibenclamide, rosiglitazone, and vildagliptin. The results of RCTs showed that all these ...Continue Reading

References

Dec 14, 2004·Genetic Epidemiology·Elias Zintzaras, John P A Ioannidis
Feb 10, 2006·JAMA : the Journal of the American Medical Association·Jaime L PetersLesley Rushton
Oct 14, 2008·Journal of Diabetes and Its Complications·Manuel González-OrtizTeresita J Beltrán-Jaramillo
Jan 22, 2010·The Cochrane Database of Systematic Reviews·Shelley R SalpeterEdwin E Salpeter Posthumous
Feb 16, 2010·Diabetes Technology & Therapeutics·G DerosaA F G Cicero
May 19, 2011·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·G DerosaP Maffioli
Nov 24, 2011·Diabetes & Metabolism Journal·Hyun Jeong Jeon, Tae Keun Oh
Jul 6, 2012·Statistics in Medicine·Dan JacksonRichard D Riley
Oct 8, 2013·PloS One·Anna ChaimaniGeorgia Salanti
Feb 21, 2014·Revista Brasileira de terapia intensiva·Lucas Lima FerreiraLuiz Carlos Marques Vanderlei
May 31, 2014·Metabolism: Clinical and Experimental·Giuseppe DerosaPamela Maffioli
Mar 17, 2016·European Journal of Clinical Pharmacology·S El MessaoudiN P Riksen

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.